⌘K (Command K) to search

Sign in Sign up free

Insider · CIK 0001924824

Garland Jonathan Todd

Reports to the SEC for 2 companies · FREMONT, CA

Transactions

19

Companies

2

Filings

6

CIK

0001924824

Forms 4 and 5

Insider transactions

19 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2024-05-06	NS Wind Down Co., Inc.M Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	+200K sh	—	—	200,000
2024-05-06	NS Wind Down Co., Inc.Restricted Stock UnitsM Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	−200K sh	—	—	0
2023-08-28	NS Wind Down Co., Inc.Restricted Stock UnitsA Award	Chief Commercial Officer	AAward	+200K sh	—	—	200,000
2023-08-18	CTKBCytek Biosciences, Inc. · Restricted Stock UnitsM Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	−1,951 sh	—	—	21,462
2023-08-18	CTKBCytek Biosciences, Inc. · Restricted Stock UnitsM Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	−2,761 sh	—	—	39,579
2023-08-18	CTKBCytek Biosciences, Inc.M Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	+1,951 sh	—	—	7,838
2023-08-18	CTKBCytek Biosciences, Inc.F Tax Payment	Chief Commercial Officer	FTax Payment	−760 sh	$8.46	−$6,429.6	7,078
2023-08-18	CTKBCytek Biosciences, Inc.M Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	+2,761 sh	—	—	9,839
2023-08-18	CTKBCytek Biosciences, Inc.F Tax Payment	Chief Commercial Officer	FTax Payment	−1,076 sh	$8.46	−$9,102.96	8,763
2023-05-18	CTKBCytek Biosciences, Inc.M Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	+7,804 sh	—	—	7,804
2023-05-18	CTKBCytek Biosciences, Inc.M Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	+1,840 sh	—	—	6,604
2023-05-18	CTKBCytek Biosciences, Inc.F Tax Payment	Chief Commercial Officer	FTax Payment	−717 sh	$6.69	−$4,796.73	5,887
2023-05-18	CTKBCytek Biosciences, Inc. · Restricted Stock UnitsM Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	−7,804 sh	—	—	23,413
2023-05-18	CTKBCytek Biosciences, Inc. · Restricted Stock UnitsM Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	−1,840 sh	—	—	42,340
2023-05-18	CTKBCytek Biosciences, Inc.F Tax Payment	Chief Commercial Officer	FTax Payment	−3,040 sh	$6.69	−$20.3K	4,764
2023-03-03	CTKBCytek Biosciences, Inc. · Restricted Stock UnitsA Award	Chief Commercial Officer	AAward	+44.2K sh	—	—	44,180
2023-03-03	CTKBCytek Biosciences, Inc. · Employee Stock Option (right to buy)A Award	Chief Commercial Officer	AAward	+66.8K sh	—	—	66,773
2022-04-25	CTKBCytek Biosciences, Inc. · Stock Option (right to buy)A Award	Chief Commercial Officer	AAward	+47K sh	—	—	46,971
2022-04-25	CTKBCytek Biosciences, Inc. · Restricted Stock UnitsA Award	Chief Commercial Officer	AAward	+31.2K sh	—	—	31,217

Recent filings

6

Accepted (ET)
May 84
Garland Jonathan Todd0001401708-24-000086
SEC(opens sec.gov)
Aug 284
Garland Jonathan Todd0001401708-23-000210
SEC(opens sec.gov)
Aug 214
Garland Jonathan Todd0001209191-23-046826
SEC(opens sec.gov)
May 194
Garland Jonathan Todd0001209191-23-031260
SEC(opens sec.gov)
Mar 74
Garland Jonathan Todd0001209191-23-016977
SEC(opens sec.gov)
Apr 274
Garland Jonathan Todd0001209191-22-025897
SEC(opens sec.gov)

Companies

2

Address

C/O CYTEK BIOSCIENCES, INC. 47215 LAKEVIEW BOULEVARD

FREMONT, CA, 94538